Compare FTAI & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTAI | STE |
|---|---|---|
| Founded | 2011 | 1985 |
| Country | United States | United States |
| Employees | 985 | 3700 |
| Industry | Misc Corporate Leasing Services | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.4B | 20.9B |
| IPO Year | N/A | 2018 |
| Metric | FTAI | STE |
|---|---|---|
| Price | $205.88 | $219.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | $274.67 | ★ $275.20 |
| AVG Volume (30 Days) | ★ 1.1M | 788.2K |
| Earning Date | 04-29-2026 | 05-11-2026 |
| Dividend Yield | 0.75% | ★ 1.19% |
| EPS Growth | N/A | ★ 27.90 |
| EPS | N/A | ★ 7.93 |
| Revenue | N/A | ★ $5,935,900,000.00 |
| Revenue This Year | $32.73 | $9.88 |
| Revenue Next Year | $51.41 | $6.32 |
| P/E Ratio | $65.85 | ★ $27.82 |
| Revenue Growth | N/A | ★ 8.73 |
| 52 Week Low | $109.90 | $195.14 |
| 52 Week High | $323.51 | $269.44 |
| Indicator | FTAI | STE |
|---|---|---|
| Relative Strength Index (RSI) | 35.34 | 56.62 |
| Support Level | $157.96 | $217.07 |
| Resistance Level | $269.05 | $227.10 |
| Average True Range (ATR) | 14.39 | 5.64 |
| MACD | -4.87 | 0.80 |
| Stochastic Oscillator | 8.51 | 80.55 |
FTAI Aviation Ltd is an independent engine maintenance platform focused on the CFM56-5B, CFM56-7B, and V2500 aircraft engines, which power the 737NG and A320ceo aircraft. The company repairs and rebuilds engines in its maintenance facilities and with joint venture partners, and sells or leases engines through its proprietary Maintenance, Repair and Exchange (MRE) model under the Aerospace Products segment, which earns maximum revenue from North America and develops, repairs/refurbishes, and sells aircraft engines and aftermarket components. It also operates an Aviation Leasing segment, owning and managing a portfolio of on- and off-lease aircraft and engines, including engine transfers for rebuilding and sales.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.